Ameriprise’s Ventyx Biosciences VTYX Stock Holding History

Ameriprise’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-28,031	Closed	-$60K	–	4193
2025 Q2	$60K	Buy	+28,031	New	+$45.3K	﹤0.01%	3912
2024 Q2	–	Sell	-22,253	Closed	-$122K	–	3945
2024 Q1	$122K	Buy	+22,253	New	+$102K	﹤0.01%	3758

Other funds holding VTYX

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise's VTYX Position: Q3 2025 in Review

Ameriprise sold out of Ventyx Biosciences (VTYX) in Q3 2025, closing a stake of 28,031 shares — an estimated $60K sold.

Ameriprise first reported a position in VTYX in Q1 2024 and held it in 2 quarters. The position peaked at $122K in Q1 2024. 110 funds tracked by Wall St. Rank hold VTYX as of Q3 2025.

Ameriprise reported no remaining Ventyx Biosciences position as of Q3 2025 after selling out during the quarter.
Ameriprise sold 28,031 Ventyx Biosciences shares in Q3 2025, an estimated $60K.
Ameriprise first reported a position in Ventyx Biosciences in Q1 2024 and held it in 2 quarters.
Ameriprise's Ventyx Biosciences position peaked at $122K in Q1 2024.
110 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q3 2025.

Based on Ameriprise's 13F filing for Q3 2025, filed 14 Nov 2025.